Gonzalo Fernández-Miranda, associate researcher at IRB Barcelona, leads this therapeutic project selected by CaixaImpulse to facilitate its development towards the market.
IRB Barcelona, along with another 30 Catalan companies and organisations, is participating in the four-day convention in San Diego.
The BIO International Convention (BIO) is the top partnering fair for the biomedical sector.
The Institute’s spin-offs Iproteos and Nostrum Biodiscovery are also visiting the fair.
Researchers led by Salvador Aznar-Benitah at IRB Barcelona investigate the role of Dnmt3a and Dnmt3b proteins in skin homeostasis and tumour development in adult mice.
The study has been published in eLife and deserved an eLife digest aimed at a more general audience.
Today in the La Vanguardia newspaper, Josep Corbella devotes an article to Barcelona's support of research with applications in regenerative medicine. Among the labs mentioned, the article makes reference to the Cellular Plasticity and Disease Laboratory of Manuel Serrano, which will study the repair mechanisms of damaged tissue for biomedical applications in several diseases, with a particular emphasis on diabetes, lung fibrosis and cardiac fibrosis. The new lab at IRB Barcelona,...
In the video "Looking for a needle in a haystack", ICREA researcher at IRB Barcelona describes her work at the front of the Biomedical Genomics laboratory.
The group’s interests range from deciphering the basic biology of cancer to the development of useful tools for the diagnosis and personalised treatment of patients.
Jeffrey M. Perkel, Nature's technology editor, writes an article on smartphone science. The article appears today in the 4 May issue of Nature magazine. The article focuses on mobile phones and how these devices are helping to take conventional laboratory-based science into the field, the classroom and the clinic.
Among other examples, Perkel discusses the work performed by Julien Colombelli, manager of the Advanced Digital Microscopy Core Facility at IRB Barcelona, who has combined, together with colleagues at ICFO and CRG...
The May issue of the American Society for Biochemistry and Molecular Biology (ASBMB) journal includes a feature article about the international project on Lafora disease, which involves Joan Guinovart’s group at IRB Barcelona (see here). The US organisation Chelsea’s Hope, a charity formed by families affected by this disease, promoted this international collaboration.
Written by Kim Rice and Matthew S. Gentry...
ACCIÓ awards the Institute’s Innovation Department with the quality seal TECNIO and two VALUNI grants for technology transfer projects
An innovative programme from IRB Barcelona’s Innovation Department enables researchers to explore how to implement their entrepreneurial ideas
How do you make a successful move from academia to industry? In March, Albert Farré, Brand Manager at Novartis Oncology, told IRB Barcelona scientists who attended the “Building Bridges in your network” workshop how he did it. And he has some good advice for budding entrepreneurs.